Petr Džubák

5.2k total citations · 1 hit paper
157 papers, 3.5k citations indexed

About

Petr Džubák is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Petr Džubák has authored 157 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 48 papers in Organic Chemistry and 24 papers in Infectious Diseases. Recurrent topics in Petr Džubák's work include HIV/AIDS drug development and treatment (23 papers), Natural product bioactivities and synthesis (21 papers) and Synthesis and Biological Evaluation (20 papers). Petr Džubák is often cited by papers focused on HIV/AIDS drug development and treatment (23 papers), Natural product bioactivities and synthesis (21 papers) and Synthesis and Biological Evaluation (20 papers). Petr Džubák collaborates with scholars based in Czechia, United States and Slovakia. Petr Džubák's co-authors include Marián Hajdúch, Jan Šarek, Milan Urban, Miroslav Kvasnica, David Biedermann, David Vydra, Lenka Marková, Daniella Zheleva, Madhu Kollareddy and Soňa Gurská and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Cancer Research.

In The Last Decade

Petr Džubák

151 papers receiving 3.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacological activities of natural triterpenoids and their therapeutic implications

2006 584 citations Petr Džubák, Marián Hajdúch et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Petr Džubák Czechia	28	2.1k	960	466	288	285	157	3.5k
Chunlin Zhuang China	33	2.4k 1.2×	1.7k 1.8×	519 1.1×	112 0.4×	205 0.7×	159	4.7k
Marie Boyd United Kingdom	25	2.0k 1.0×	1.3k 1.4×	722 1.5×	124 0.4×	385 1.4×	73	4.6k
Afzal Hussain Saudi Arabia	34	1.5k 0.7×	487 0.5×	324 0.7×	124 0.4×	286 1.0×	137	3.2k
Wannian Zhang China	33	1.8k 0.8×	1.2k 1.3×	485 1.0×	73 0.3×	173 0.6×	132	3.3k
Hsing‐Pang Hsieh Taiwan	44	2.3k 1.1×	2.1k 2.2×	832 1.8×	422 1.5×	164 0.6×	152	5.3k
Xiayang Qiu United States	34	2.4k 1.2×	804 0.8×	624 1.3×	121 0.4×	173 0.6×	61	4.9k
Kyeong Lee South Korea	39	2.9k 1.4×	1.3k 1.3×	660 1.4×	168 0.6×	232 0.8×	215	5.2k
Vanicha Vichai Thailand	13	1.6k 0.8×	696 0.7×	516 1.1×	163 0.6×	331 1.2×	30	3.4k
Sabrina Dallavalle Italy	32	2.1k 1.0×	1.3k 1.4×	632 1.4×	90 0.3×	252 0.9×	176	3.7k
Matthias Ocker Germany	39	2.9k 1.4×	419 0.4×	1.1k 2.3×	262 0.9×	172 0.6×	161	5.0k

Countries citing papers authored by Petr Džubák

Since Specialization

Citations

This map shows the geographic impact of Petr Džubák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Džubák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Džubák more than expected).

Fields of papers citing papers by Petr Džubák

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petr Džubák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Džubák. The network helps show where Petr Džubák may publish in the future.

Co-authorship network of co-authors of Petr Džubák

This figure shows the co-authorship network connecting the top 25 collaborators of Petr Džubák. A scholar is included among the top collaborators of Petr Džubák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petr Džubák. Petr Džubák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jurášek, Michal, Eduarda Dráberová, Jiřı́ Řehulka, et al.. (2025). Colchicine-BODIPY Probes: Evidence for the Involvement of Intracellular Membranes in the Targeting of Colchicine to Tubulin. ACS Pharmacology & Translational Science. 8(7). 1965–1985.

Džubák, Petr, et al.. (2024). Near-infrared pH-switchable BODIPY photosensitizers for dual biotin/cRGD targeted photodynamic therapy. Journal of Photochemistry and Photobiology B Biology. 259. 113010–113010. 7 indexed citations

Béreš, Tibor, et al.. (2024). Secondary metabolite profiles and anti‐SARS‐CoV‐2 activity of ethanolic extracts from nine genotypes of Cannabis sativa L.. Archiv der Pharmazie. 358(1). e2400607–e2400607. 4 indexed citations

Kazakova, Anna N., Ivo Frydrych, J. Pokorný, et al.. (2024). Triterpenoid phthalimides as selective anti-cancer agents targeting mitochondrial apoptosis. European Journal of Medicinal Chemistry. 283. 117126–117126.

Dostál, Jiřı́, et al.. (2023). Tissue expression analysis of cervical mucus proteome. 88(1). 4–12. 1 indexed citations

Gurská, Soňa, et al.. (2023). Synthesis and Biological Evaluation of Oxindole Sulfonamide Derivatives as Bruton's Tyrosine Kinase Inhibitors**. ChemMedChem. 19(1). e202300511–e202300511. 4 indexed citations

Oždian, Tomáš, Jana Václavková, Michal Ješeta, et al.. (2023). Proteome Mapping of Cervical Mucus and Its Potential as a Source of Biomarkers in Female Tract Disorders. International Journal of Molecular Sciences. 24(2). 1038–1038. 6 indexed citations

Frydrych, Ivo, Barbora Lišková, Soňa Gurská, et al.. (2022). Lupane derivatives containing various aryl substituents in the position 3 have selective cytostatic effect in leukemic cancer cells including resistant phenotypes. European Journal of Medicinal Chemistry. 244. 114850–114850. 4 indexed citations

Fernández-Moreira, Esteban, Michael R. Mijares, Juan Bautista De Sanctis, et al.. (2022). Synthesis, Leishmanicidal, Trypanocidal, Antiproliferative Assay and Apoptotic Induction of (2-Phenoxypyridin-3-yl)naphthalene-1(2H)-one Derivatives. Molecules. 27(17). 5626–5626. 2 indexed citations

10.

Illéš, Peter, Soňa Gurská, Petr Džubák, et al.. (2022). Mixture Effects of Tryptophan Intestinal Microbial Metabolites on Aryl Hydrocarbon Receptor Activity. International Journal of Molecular Sciences. 23(18). 10825–10825. 17 indexed citations

11.

Koudeláková, Vladimíra, et al.. (2022). Evaluation of Non-Invasive Gargle Lavage Sampling for the Detection of SARS-CoV-2 Using rRT-PCR or Antigen Assay. Viruses. 14(12). 2829–2829. 2 indexed citations

12.

Frydrych, Ivo, J. Pokorný, Martin Vlk, et al.. (2022). Triterpenoid pyrazines and pyridines – Synthesis, cytotoxicity, mechanism of action, preparation of prodrugs. European Journal of Medicinal Chemistry. 243. 114777–114777. 13 indexed citations

13.

Rumlová, Michaela, Petr Džubák, Jiřı́ Řehulka, et al.. (2021). Betulinic Acid Decorated with Polar Groups and Blue Emitting BODIPY Dye: Synthesis, Cytotoxicity, Cell-Cycle Analysis and Anti-HIV Profiling. Biomedicines. 9(9). 1104–1104. 9 indexed citations

14.

Pika, Tomáš, et al.. (2019). Mass Spectrometry Amyloid Typing Is Reproducible across Multiple Organ Sites. BioMed Research International. 2019. 1–9. 19 indexed citations

15.

Džubák, Petr, et al.. (2018). A Synthetic Approach for the Rapid Preparation of BODIPY Conjugates and their use in Imaging of Cellular Drug Uptake and Distribution. Chemistry - A European Journal. 24(19). 4957–4966. 40 indexed citations

16.

Voller, Jiří, Tibor Béreš, Marek Zatloukal, et al.. (2017). The natural cytokinin 2OH3MeOBAR induces cell death by a mechanism that is different from that of the “classical” cytokinin ribosides. Phytochemistry. 136. 156–164. 13 indexed citations

17.

Perlíková, Pavla, Petr Nauš, Tomáš Elbert, et al.. (2016). 7-(2-Thienyl)-7-Deazaadenosine (AB61), a New Potent Nucleoside Cytostatic with a Complex Mode of Action. Molecular Cancer Therapeutics. 15(5). 922–937. 27 indexed citations

18.

Gurská, Soňa, Petr Džubák, Marián Hajdúch, et al.. (2016). Lupane and 18α-oleanane derivatives substituted in the position 2, their cytotoxicity and influence on cancer cells. European Journal of Medicinal Chemistry. 121. 120–131. 21 indexed citations

19.

Jurášek, Michal, Petr Džubák, David Sedlák, et al.. (2013). Preparation, preliminary screening of new types of steroid conjugates and their activities on steroid receptors. Steroids. 78(3). 356–361. 28 indexed citations

20.

Urban, Milan, Martin Vlk, Petr Džubák, Marián Hajdúch, & Jan Šarek. (2012). Cytotoxic heterocyclic triterpenoids derived from betulin and betulinic acid. Bioorganic & Medicinal Chemistry. 20(11). 3666–3674. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact